P300 downregulation using specific siRNAs reduced N-Myc expression levels in MYCN-amplified NB cells, but NAT10 siRNAs failed to do so (Figs. 4, D and E and S1, G and H). The gene discussed is MYCN; the disease is neuroblastoma.